This document summarizes information about the drug Therabloc, including its brand name, generic name, indications, drug classification, mechanism of action, dosage, precautions, adverse reactions, contraindications, forms, and nursing responsibilities. Therabloc is used to treat hypertension, angina pectoris, and acute myocardial infarction by blocking beta1 adrenergic receptors, decreasing blood pressure, heart rate, and attacks of angina. Special precautions are needed for patients with renal or liver impairment and dosages may need to be adjusted. Common adverse reactions include fatigue, dizziness, bronchospasm, and hypotension. Nurses should monitor vital signs, ECG, intake/output, and for signs of
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
This document summarizes information about the drug Therabloc, including its brand name, generic name, indications, drug classification, mechanism of action, dosage, precautions, adverse reactions, contraindications, forms, and nursing responsibilities. Therabloc is used to treat hypertension, angina pectoris, and acute myocardial infarction by blocking beta1 adrenergic receptors, decreasing blood pressure, heart rate, and attacks of angina. Special precautions are needed for patients with renal or liver impairment and dosages may need to be adjusted. Common adverse reactions include fatigue, dizziness, bronchospasm, and hypotension. Nurses should monitor vital signs, ECG, intake/output, and for signs of
This document summarizes information about the drug Therabloc, including its brand name, generic name, indications, drug classification, mechanism of action, dosage, precautions, adverse reactions, contraindications, forms, and nursing responsibilities. Therabloc is used to treat hypertension, angina pectoris, and acute myocardial infarction by blocking beta1 adrenergic receptors, decreasing blood pressure, heart rate, and attacks of angina. Special precautions are needed for patients with renal or liver impairment and dosages may need to be adjusted. Common adverse reactions include fatigue, dizziness, bronchospasm, and hypotension. Nurses should monitor vital signs, ECG, intake/output, and for signs of
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
This document summarizes information about the drug Therabloc, including its brand name, generic name, indications, drug classification, mechanism of action, dosage, precautions, adverse reactions, contraindications, forms, and nursing responsibilities. Therabloc is used to treat hypertension, angina pectoris, and acute myocardial infarction by blocking beta1 adrenergic receptors, decreasing blood pressure, heart rate, and attacks of angina. Special precautions are needed for patients with renal or liver impairment and dosages may need to be adjusted. Common adverse reactions include fatigue, dizziness, bronchospasm, and hypotension. Nurses should monitor vital signs, ECG, intake/output, and for signs of
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Download as doc, pdf, or txt
You are on page 1of 3
Brand Name: Therabloc
Generic Name: Hypertension, angina pectoris, acute MI
Indications: Hypertension; angina pectoris; MCI; PVC; unlabeled uses: prevention of migraine headaches, management of tremors, alcohol withdrawal, and anxiety. Drug Classification: Antihypertensive, Antianginal, Antiarryhthmic Mechanism of Action: Block stimulation of beta1 (myocardial) adrenergic receptors. Do not usually affect beta2 (pulmonary, vascular, uterine) receptor sites. Therapeutic Effects: decreased blood pressure and heart rate, decreased frequency of attacks of angina pectoris, slowing of ventricular response. Dosage: PO (Adults): Antianginal- 50 mg once daily initially, may be increased after 1 week to 100 mg/day may then be increased as needed. Antihypertensive- 25-50 mg once daily initially, may be increased after 2 wk to 50-100 mg once daily. MCI- 50 mg (given 10 min following last IV dose), then 50 mg 12 hr later, then 100 mg/day as a single dose or in 2 divided doses for 6-9 days or until hospital discharge. Special Precaution: Patients with renal impairment, hepatic impairment, pulmonary disease, diabetes mellitus, thyrotoxicosis, with a history of severe allergic reactions, geriatric patients, pregnant and lactating women Pregnancy Risk Category: B Adverse Reaction: CNS: fatigue, weakness, dizziness, depression, insomnia, memory loss, mental stats changes, nightmares, anxiety, nervousness, drowsiness. EENT: blurred vision, stuffy nose. Resp: bronchospasm, wheezing. CV: bradycardia, congestive heart failure, pulmonary edema, peripheral vasoconstriction, hypotension. GI: constipation, diarrhea, nausea, vomiting, liver function abnormalities. GU: impotence, decreased libido, urinary frequency. Derm: rashes Endo: hyperglycemia, hypoglycemia MS: joint pain, back pain, arthralgia Contraindications: Uncompensated congestive heart failure, pulmonary edema, cardiogenic shock, bradycardia of heart block Form: Tablets: 25 mg, 50 mg, 100 mg, Injection: 500 mcg Nursing Responsibilities: Monitor vital signs and ECG should be monitored q 5-15 min during and for several hours after parenteral administration. Administer atropine if heart rate is <40 bpm, especially if cardiac output is decreased. Monitor intake and output ratios and daily weights. Assess routinely for signs and symptoms of CHF.